NovoSeven

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Eptacog alfa (activated) 2.4mg (120 KIU)

Available from:

Novo Nordisk Pharmaceuticals Ltd

INN (International Name):

Eptacog alfa (activated) 2.4 mg (120 KIU)

Dosage:

2.4 mg

Pharmaceutical form:

Powder for injection

Composition:

Active: Eptacog alfa (activated) 2.4mg (120 KIU) Excipient: Calcium chloride dihydrate Glycylglycine Mannitol Polysorbate 80 Sodium chloride Water for injection

Units in package:

Combination pack, 1x(powder + diluent), 2.4 mg

Class:

General sale

Prescription type:

General sale

Manufactured by:

Novo Nordisk A/S

Product summary:

Package - Contents - Shelf Life: Combination pack, 1x(powder + diluent) - 2.4 mg - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at or below 25°C protect from light. do not freeze - Vial, glass, powder - 2.4 mg - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light - Vial, glass, Diluent, 4.3mL - 4.3 mL - 48 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Authorization date:

1994-07-04